Enhancing the value of the oncology thoracic surgery care pathway: a TDABC and ABC analysis.

Activity-Based Costing (ABC) Care pathways Oncology Thoracic surgery Time-Driven activity-based costing (TDABC) Value-Based Healthcare (VBHC)

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
28 Oct 2024
Historique:
received: 30 10 2023
accepted: 23 10 2024
medline: 29 10 2024
pubmed: 29 10 2024
entrez: 29 10 2024
Statut: epublish

Résumé

Time-driven activity-based costing (TDABC) and activity-based costing (ABC) are methods used in the healthcare sector to assess the costs of patient care pathways. These methods help identify opportunities for optimizing and reducing activity times without compromising the quality of care. TDABC is recommended in the Value-Based Healthcare (VBHC) model to assess the outcomes of care pathways in relation to their associated costs. By focusing on the creation of value for patients, TDABC helps identify the interventions and processes that provide the most value in terms of clinical outcomes and patient satisfaction. This enables healthcare organizations to make informed decisions on improvements that will maximize value for patients. The aim of the study is to evaluate the cost of the oncology thoracic surgery care pathway prior to and following the implementation of digital health solution. We have chosen to use the TDABC and ABC methods to calculate the costs of care pathway for oncology patients undergoing thoracic surgery in two healthcare establishments prior to and following the implementation of a digital health solution. By using these methods, we were able to calculate the costs associated with each stage of the patients' care pathway. This has given us a clearer picture of the costs associated with each activity and a better understanding of the sources of expenditure. The results show that implementing the digital health solution and applying the principles of the VBHC model have provided tangible benefits in terms of reviewing processes and the roles of the various players involved, eliminating unnecessary or non-value-added activities, automating administrative or repetitive tasks, and improving coordination between the two healthcare establishments and between healthcare professionals. These improvements have contributed to better patient care. Given the success observed in this pilot project, decision-makers chose to persistently implement this digital health solution for specific care pathways over the long term. Additionally, there is a commitment to further enhance the platform to align closely with the needs and the expectations of healthcare professionals. This proactive approach aims to ensure optimal utilization of resources, ultimately providing the best care to patients.

Sections du résumé

BACKGROUND BACKGROUND
Time-driven activity-based costing (TDABC) and activity-based costing (ABC) are methods used in the healthcare sector to assess the costs of patient care pathways. These methods help identify opportunities for optimizing and reducing activity times without compromising the quality of care. TDABC is recommended in the Value-Based Healthcare (VBHC) model to assess the outcomes of care pathways in relation to their associated costs. By focusing on the creation of value for patients, TDABC helps identify the interventions and processes that provide the most value in terms of clinical outcomes and patient satisfaction. This enables healthcare organizations to make informed decisions on improvements that will maximize value for patients. The aim of the study is to evaluate the cost of the oncology thoracic surgery care pathway prior to and following the implementation of digital health solution.
METHODS METHODS
We have chosen to use the TDABC and ABC methods to calculate the costs of care pathway for oncology patients undergoing thoracic surgery in two healthcare establishments prior to and following the implementation of a digital health solution. By using these methods, we were able to calculate the costs associated with each stage of the patients' care pathway. This has given us a clearer picture of the costs associated with each activity and a better understanding of the sources of expenditure.
RESULTS RESULTS
The results show that implementing the digital health solution and applying the principles of the VBHC model have provided tangible benefits in terms of reviewing processes and the roles of the various players involved, eliminating unnecessary or non-value-added activities, automating administrative or repetitive tasks, and improving coordination between the two healthcare establishments and between healthcare professionals. These improvements have contributed to better patient care.
CONCLUSIONS CONCLUSIONS
Given the success observed in this pilot project, decision-makers chose to persistently implement this digital health solution for specific care pathways over the long term. Additionally, there is a commitment to further enhance the platform to align closely with the needs and the expectations of healthcare professionals. This proactive approach aims to ensure optimal utilization of resources, ultimately providing the best care to patients.

Identifiants

pubmed: 39468543
doi: 10.1186/s12913-024-11829-9
pii: 10.1186/s12913-024-11829-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1294

Subventions

Organisme : Fonds de soutien à l'innovation en santé et en services sociaux
ID : 2-2-21
Organisme : Fonds de soutien à l'innovation en santé et en services sociaux
ID : 2-2-21

Informations de copyright

© 2024. The Author(s).

Références

Peng J, Zhang M, Yu P, Wang N. Can single disease payment system based on clinical pathway reduce hospitalization costs in rural area? A case study of uterine leiomyoma in Anhui, China. BMC Health Serv Res. 2018;18(1):990. https://doi.org/10.1186/s12913-018-3807-1 .
doi: 10.1186/s12913-018-3807-1 pubmed: 30572899 pmcid: 6302448
Van Citters AD, Fahlman C, Goldmann DA, Lieberman JR, Koenig KM, DiGioia AM 3rd, O’Donnell B, Martin J, Federico FA, Bankowitz RA, Nelson EC, Bozic KJ. Developing a pathway for high-value, patient-centered total joint arthroplasty. Clin Orthop Relat Res. 2014;472(5):1619–35. https://doi.org/10.1007/s11999-013-3398-4 .
doi: 10.1007/s11999-013-3398-4 pubmed: 24297106
Shakirah MS, Jamalludin AR, Hasniah AL, Rus Anida A, Mariana D, Ahmad Fadzil A, et al. Paediatric asthma clinical pathway: impact on cost and quality of care. Med J Malaysia. 2019;74(2):138–44.
pubmed: 31079125
Castonguay J. Analyse comparative des mécanismes de financement des hôpitaux. St. Louis: Federal Reserve Bank of St Louis; 2013.
Sutherland J. Mécanismes de financement des hôpitaux :Aperçu et options pour le Canada. Fondation canadienne de la recherche sur les services de santé; Série d'études de la FCRSSS sur les générateurs de coûts et l'efficience du système de santé; rapport 4; Ontario, Canada. 2011; p. 1–28. ISBN: 9781927024010.
Lacoursière A. Financement à l’activité: Québec tente l’expérience en radio-oncologie. La Presse;Québec, Canada. 2015.
Kuchta D, Ząbek S. Activity-based costing for health care institutions. In: 8th International Conference on Enterprise Systems, Accounting and Logistics (8th ICESAL 2011). 2011.
Kaplan RS. Improving value with TDABC. Healthc Financ Manage. 2014;68(6):76–83.
pubmed: 24968629
Cannavacciuolo L, Illario M, Ippolito A, Ponsiglione C. An activity-based costing approach for detecting inefficiencies of healthcare processes. Bus Process Manag J. 2015;21(1):55. https://doi.org/10.1108/bpmj-11-2013-0144 .
doi: 10.1108/bpmj-11-2013-0144
Kaplan RS, Witkowski M, Abbott M, Guzman AB, Higgins LD, Meara JG, Padden E, Shah AS, Waters P, Weidemeier M, Wertheimer S, Feeley TW. Using time-driven activity-based costing to identify value improvement opportunities in healthcare. J Healthc Manag. 2014;59(6):399–413. https://doi.org/10.1097/00115514-201411000-00005 .
doi: 10.1097/00115514-201411000-00005 pubmed: 25647962
Nabelsi V, Plouffe V. Breast cancer treatment pathway improvement using time-driven activity-based costing. Int J Health Plann Manage. 2019;34(4):e1736–46. https://doi.org/10.1002/hpm.2887 .
doi: 10.1002/hpm.2887 pubmed: 31429493
Campanale C, Cinquini L, Tenucci A. Time-driven activity-based costing to improve transparency and decision making in healthcare. Qual Res Account Manag. 2014;11(2):165–86. https://doi.org/10.1108/QRAM-04-2014-0036 .
doi: 10.1108/QRAM-04-2014-0036
Kinsman L, Rotter T, James E, Snow P, Willis J. What is a clinical pathway? Development of a definition to inform the debate. BMC Med. 2010;8(1):31. https://doi.org/10.1186/1741-7015-8-31 .
doi: 10.1186/1741-7015-8-31 pubmed: 20507550 pmcid: 2893088
Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. BMJ. 1998;316(7125):133–7. https://doi.org/10.1136/bmj.316.7125.133 .
doi: 10.1136/bmj.316.7125.133 pubmed: 9462322 pmcid: 2665398
Foni NO, Costa LAV, Paião ID, Oliveira IO, Carvalho RT, Lenza M, et al. Clinical pathway improves medical practice in total knee arthroplasty. PloS One. 2020;15(5):e0232881. https://doi.org/10.1371/journal.pone.0232881
doi: 10.1371/journal.pone.0232881 pubmed: 32379840 pmcid: 7205292
Kwon H, Lee J-H, Woo J, Lim W, Moon B-I, Paik NS. Efficacy of a clinical pathway for patients with thyroid cancer. Head Neck. 2018;40(9):1909–16. https://doi.org/10.1002/hed.25175 .
doi: 10.1002/hed.25175 pubmed: 29637689
Street A, Vitikainen K, Bjorvatn A, Hvenegaard A. Introducing activity-based financing: a review of experience in Australia, Denmark, Norway and Sweden. No 030cherp, Working Papers from Centre for Health Economics; University of York; Heslington, England. 2007.
Sutherland J, Repin N, Crump RT. Financer des services de santé et sociaux à Montréal (Québec): un examen des mécanismes de financement et du rôle des incitations. Fondation canadienne pour l’amélioration des services de santé; Ottawa, Canada. 2013. p. 1–61.
Institut canadien d’information sur la santé. Introduction au financement fondé sur les activités; Ontario, Canada; IRSC. 2010. 11 pages.
Fetter RB, Shin Y, Freeman JL, Averill RF, Thompson JD. Case Mix Definition by Diagnosis-Related Groups. Med Care. 1980;18(2):i–53.
Fetter RB. DRGs - fact and fiction. Aust Health Rev. 1985;8(2):105–15.
pubmed: 10311260
Institut canadien d’information sur la santé. Estimateur des coûts par patient Notes méthodologiques et glossaire; Ontario, Canada; IRSC. 2015. https://www.cihi.ca/sites/default/files/document/patientcost-estimator-meth-notesfr.pdf .
Fourie C, Biller-Andorno N, Wild V. Systematically evaluating the impact of diagnosis-related groups (DRGs) on health care delivery: a matrix of ethical implications. Health Policy. 2014;115(2–3):157–64. https://doi.org/10.1016/j.healthpol.2013.11.014 .
doi: 10.1016/j.healthpol.2013.11.014 pubmed: 24388050
Or Z. Implementation of DRG payment in France: issues and recent developments. Health Policy. 2014;117(2):146–50. https://doi.org/10.1016/j.healthpol.2014.05.006 .
doi: 10.1016/j.healthpol.2014.05.006 pubmed: 24962536
25. Kastberg G, Siverbo S. Activity-based financing of health care - experiences from Sweden. Int J Health Plann Manage. 2007;22(1):25–44; doi:10.1002/hpm.868.
doi: 10.1002/hpm.868 pubmed: 17385331
26. Thomson W, Paquet R, Shedleur P. Pour que l’argent suive le patient : l’implantation du financement axé sur les patients dans le secteur de la santé. Québec: Gouvernement du Québec; 2014.
Colwyn Jones T, Dugdale D. The ABC bandwagon and the juggernaut of modernity. Accounting, Organizations and Society. 2002;27(1–2):121–63. https://doi.org/10.1016/S0361-3682(01)00035-6 .
doi: 10.1016/S0361-3682(01)00035-6
Cooper R, Kaplan RS. How cost accounting distorts product costs. Manage Account. 1988;69(10):20.
Cooper R, Kaplan RS. Measure costs right: make the right decision. Harv Bus Rev. 1988;66(5):96–103.
Cooper RG, Kleinschmidt EJ. What makes a new product a winner: success factors at the project level. RD Manag. 1987;17(3):175–89.
Kaplan R, Anderson SJ. TDABC: Méthode ABC pilotée par le temps; Édition d'Organisation; Paris, France. 2008. p. 354. ISBN:9782212539424.
Porter ME, Lee TH. The strategy that will fix health care. Harv Bus Rev. 2013;91(10):50–70.
Etges AB, Polanczyk CA, Urman RD. A standardized framework to evaluate the quality of studies using TDABC in healthcare: the TDABC in healthcare consortium consensus statement. BMC Health Serv Res. 2020;20(1):1107. https://doi.org/10.1186/s12913-020-05869-0 .
doi: 10.1186/s12913-020-05869-0 pubmed: 33256733 pmcid: 7706254
Etges APBDS, Ruschel KB, Polanczyk CA, Urman RD. Advances in value-based healthcare by the application of time-driven activity-based costing for inpatient management: a systematic review. Value Health. 2020;23(6):812–23. https://doi.org/10.1016/j.jval.2020.02.004 .
doi: 10.1016/j.jval.2020.02.004 pubmed: 32540239
Chen A, Sabharwal S, Akhtar K, Makaram N, Gupte CM. Time-driven activity-based costing of total knee replacement surgery at a London teaching hospital. Knee. 2015;22(6):640–5. https://doi.org/10.1016/j.knee.2015.07.006 .
doi: 10.1016/j.knee.2015.07.006 pubmed: 26234746
Schutzer ME, Arthur DW, Anscher MS. Time driven activity-based costing: an economic analysis of whole-breast radiation therapy versus balloon-based brachytherapy in the management of early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2014;90(1, Supplement):S587. https://doi.org/10.1016/j.ijrobp.2014.05.1765 .
doi: 10.1016/j.ijrobp.2014.05.1765
Yun BJ, Prabhakar AM, Warsh J, Kaplan R, Brennan J, Dempsey KE, Raja AS. Time-driven activity-based costing in emergency medicine. Ann Emerg Med. 2016;67(6):765-72. https://doi.org/10.1016/j.annemergmed.2015.08.004 .
Domingo H, Eggrickx A, Naro G, Bourret R. Le Time Driven Activity Based Costing (TDABC), modèle de calcul de coût adapté au parcours de soins des maladies chroniques ? Cas du parcours de soins de l’accident vasculaire cérébral (AVC). Gestion et management public. 2018;6 / 3(1):71–93.
doi: 10.3917/gmp.063.0071
Kaplan RS, Anderson SR. Time-Driven Activity-Based Costing. Harv Bus Rev. 2004;82(11):131–8.
pubmed: 15559451
Everaert P, Bruggeman W, Sarens G, Anderson SR, Levant Y. Cost modeling in logistics using time-driven ABC: experiences from a wholesaler. Int J Phys Distrib Logist Manag. 2008;38(3):172–91. https://doi.org/10.1108/09600030810866977 .
doi: 10.1108/09600030810866977
da Silva Etges APB, Cruz LN, Notti RK, Neyeloff JL, Schlatter RP, Astigarraga CC, et al. An 8-step framework for implementing time-driven activity-based costing in healthcare studies. Eur J Health Econ. 2019;20(8):1133–45. https://doi.org/10.1007/s10198-019-01085-8 .
doi: 10.1007/s10198-019-01085-8 pubmed: 31286291
Vanhaecht K, Ovretveit J, Elliott MJ, Sermeus W, Ellershaw J, Panella M. Have we drawn the wrong conclusions about the value of care pathways? Is a Cochrane review appropriate? Eval Health Prof. 2012;35(1):28–42. https://doi.org/10.1177/0163278711408293 .
doi: 10.1177/0163278711408293 pubmed: 21708891
Rotter T, Kinsman L, James E, Machotta A, Willis J, Snow P, Kugler J. The effects of clinical pathways on professional practice, patient outcomes, length of stay, and hospital costs: cochrane systematic review and meta-analysis. Eval Health Prof. 2012;35(1):3–27. https://doi.org/10.1177/0163278711407313 .
doi: 10.1177/0163278711407313 pubmed: 21613244
Barbieri A, Vanhaecht K, Van Herck P, Sermeus W, Faggiano F, Marchisio Marchisio, Panella M. Effects of clinical pathways in the joint replacement: a meta-analysis. BMC Med. 2009;7(1):32. https://doi.org/10.1186/1741-7015-7-32 .
doi: 10.1186/1741-7015-7-32 pubmed: 19570193 pmcid: 2715423
Porter ME, Teisberg EO. Redefining health care: creating value-based competition on results: Harvard Business School Press; Boston, USA. 2006.
Waters PM. Value in pediatric orthopaedic surgery health care: the role of time-driven activity-based cost accounting (TDABC) and standardized clinical assessment and management plans (SCAMPs). J Pediatr Orthop. 2015;35(5):S45–7. https://doi.org/10.1097/BPO.0000000000000547 .
doi: 10.1097/BPO.0000000000000547 pubmed: 26049304
Simmonds J, Hollis R, Tamberino RK, Vecchiotti MA, Scott AR. Comparing the real and perceived cost of adenotonsillectomy using time-driven activity-based costing. Laryngoscope. 2019;129(6):1347–53. https://doi.org/10.1002/lary.27648 .
doi: 10.1002/lary.27648 pubmed: 30565229

Auteurs

Véronique Nabelsi (V)

Department of Administrative Sciences, Université du Québec en Outaouais, C.P. 1240, Succ. Hull , Gatineau, J8X 3X7, Canada. veronique.nabelsi@uqo.ca.

Véronique Plouffe (V)

Department of Accounting, Université du Québec en Outaouais, C.P. 1240, Succ. Hull, Gatineau, J8X 3X7, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH